TABLE 2.

Percentages of subjects with hSBA titers ≥4 and rSBA titers ≥8 before and at 1, 2, 12, and 24 months after administration of Menitorix

ParameterResult for the following time (mo) after administration of Menitorix:
0121224
% of subjects with hSBA titer ≥416 (8/49)a94 (46/49)82 (37/45)31 (15/49)24 (12/49)
% of subjects with rSBA titer ≥831 (15/49)92 (46/50)92 (44/48)54 (27/50)30 (15/50)
  • a The data in parentheses indicate the number of subjects with the indicated titer/total number of subjects evaluated.